COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 2062: Articles 20611-20620  | Next

Are psychiatric disorders risk factors for COVID-19 susceptibility and severity?a two-sample, bidirectional, univariable and multivariable Mendelian Randomization study
Luykx, J., Lin, B.
10.1101/2020.11.29.20240481 — Posted: 2020-11-30
Impact of the COVID-19 pandemic on developmental care practices for infants born preterm
Scala, M., Marchman, V. A., Brignoni-Perez, E., Chan Morales, M., Travis, K. E.
10.1101/2020.11.25.20238956 — Posted: 2020-11-30
Coronavirus(COVID-19)Outbreak Prediction Using Epidemiological Models of Richards Gompertz Logistic Ratkowsky and SIRD
Sedaghat, A., Oloomi, S. A. A., Malayer, M. A., Rezaei, N., MOSAVI, A.
10.1101/2020.11.29.20240580 — Posted: 2020-11-30
Predicting COVID-19(Coronavirus Disease)Outbreak Dynamics Using SIR-based Models: Comparative Analysis of SIRD and Weibull-SIRD
Sedaghat, A., MOSAVI, A.
10.1101/2020.11.29.20240564 — Posted: 2020-11-30
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates
Seedat, S., Chemaitelly, H., Ayoub, H., Makhoul, M., Mumtaz, G. R., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Bertollini, R., Abu-Raddad, L. J.
10.1101/2020.11.29.20240416 — Posted: 2020-11-30
Optimal shutdown strategies for COVID-19 with economic and mortality costs: BC as a case study
Barlow, M. T., Marshall, N. D., Tyson, R. C.
10.1101/2020.11.25.20239004 — Posted: 2020-11-30
Universities and COVID-19 Growth at the Start of the 2020 Academic Year
Penuliar, M. S., Clark, C., Curti, D., Hudson, C., Philips, B.
10.1101/2020.11.25.20238899 — Posted: 2020-11-30
Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study
Surendra, H., Elyazar, I. R., Djaafara, B. A., Ekawati, L. L., Saraswati, K., Adrian, V., Widyastuti, W., Oktavia, D., Salama, N., Lina, R. N., Andrianto, A., Lestari, K. D., Burhan, E., Shankar, A. H., Thwaites, G., Baird, J. K., Hamers, R. L.
10.1101/2020.11.25.20235366 — Posted: 2020-11-30
Time trends in infectious and chronic disease consultations in Dakar, Senegal: Impact of Covid-19 Sanitary Measures
Gaye, B., Diop, M., Khoury, S., Asselin, A., Kingue, S., Nguetta, R., Diop, I. B., Lassale, C., Cene, C., Jouven, X.
10.1101/2020.11.26.20239129 — Posted: 2020-11-30
COVID-19 Workplace Outbreaks by Industry Sector and their Associated Household Transmission, Ontario, Canada, January to June, 2020
Murti, M., Achonu, C., Smith, B. T., Brown, K. A., Kim, J. H., Johnson, J., Ravindran, S., Buchan, S. A.
10.1101/2020.11.25.20239038 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).